Stock Analysis on Net
Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

Johnson & Johnson, common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Mar 29, 2026 Dec 28, 2025 Sep 28, 2025 Jun 29, 2025 Mar 30, 2025 Dec 29, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021
Loans and notes payable 8.69 4.26 3.31 5.96 7.18 3.32 2.50 5.44 4.97 2.06 2.33 6.10 9.17 6.82 2.53 2.42 2.41 2.07 2.12 1.80 1.94
Accounts payable 5.21 6.02 4.99 4.89 4.93 5.73 5.02 4.89 4.75 5.75 5.03 5.45 5.06 6.25 5.80 5.49 5.22 6.07 5.00 4.93 4.93
Accrued liabilities 3.68 4.31 3.94 3.83 4.09 4.75 6.42 5.82 6.00 6.09 6.08 5.53 5.72 6.11 6.83 7.09 7.29 7.48 7.71 5.94 7.66
Accrued rebates, returns and promotions 9.16 9.60 11.08 10.77 9.70 9.76 10.34 9.69 9.41 9.55 9.52 8.18 7.54 7.69 8.01 7.57 7.27 6.64 7.08 7.06 6.91
Accrued compensation and employee related obligations 1.45 2.28 2.06 1.71 1.32 2.29 2.03 1.57 1.27 2.38 2.01 1.60 1.14 1.78 1.72 1.53 1.18 1.97 1.76 1.54 1.19
Accrued taxes on income 0.54 0.70 1.00 0.86 2.18 2.09 2.71 2.38 1.93 1.79 1.75 1.40 2.18 1.14 1.13 1.11 0.96 0.61 1.21 0.68 1.09
Current liabilities 28.73% 27.17% 26.38% 28.02% 29.38% 27.94% 29.03% 29.78% 28.33% 27.62% 26.72% 28.26% 30.81% 29.78% 26.01% 25.22% 24.33% 24.85% 24.86% 21.95% 23.72%
Long-term debt, excluding current portion 18.68 19.80 20.44 20.29 19.80 17.02 17.55 17.47 14.59 15.45 15.69 17.69 17.82 14.35 15.76 15.92 16.18 16.47 16.81 17.18 17.54
Deferred taxes on income 3.49 3.41 3.11 1.96 1.25 1.36 1.66 1.46 1.84 1.91 1.58 1.89 2.25 3.40 2.82 2.82 3.60 4.11 3.99 5.11 3.77
Employee related obligations 3.36 3.49 3.59 3.63 3.64 4.03 3.84 3.82 4.08 4.27 3.42 3.37 3.40 3.61 4.77 4.81 4.90 4.89 5.67 5.88 6.09
Long-term taxes payable 0.24 0.24 0.22 0.22 0.20 0.22 0.20 0.19 1.68 1.72 1.53 1.32 2.19 2.30 2.38 2.34 3.22 3.14 3.22 3.24 3.81
Other liabilities 5.08 4.95 5.15 5.31 5.39 9.74 8.37 7.78 8.76 8.00 8.17 7.61 7.36 5.57 5.66 5.92 5.89 5.87 6.24 7.21 6.92
Non-current liabilities 30.86% 31.90% 32.50% 31.41% 30.29% 32.37% 31.62% 30.71% 30.95% 31.33% 30.39% 31.88% 33.03% 29.23% 31.40% 31.82% 33.78% 34.49% 35.93% 38.62% 38.13%
Total liabilities 59.59% 59.07% 58.88% 59.42% 59.67% 60.31% 60.65% 60.50% 59.28% 58.96% 57.11% 60.14% 63.84% 59.01% 57.40% 57.04% 58.11% 59.33% 60.79% 60.56% 61.85%
Common stock, par value $1.00 per share 1.55 1.57 1.62 1.61 1.61 1.73 1.75 1.72 1.81 1.86 1.88 1.63 1.59 1.67 1.78 1.76 1.75 1.71 1.74 1.77 1.81
Accumulated other comprehensive loss -7.38 -7.49 -7.90 -7.40 -6.06 -6.52 -7.02 -6.21 -6.26 -7.48 -5.29 -6.85 -6.44 -6.92 -8.73 -7.79 -7.71 -7.17 -8.60 -8.56 -8.88
Retained earnings and Additional paid-in capital 84.20 84.82 86.76 85.51 83.97 86.50 87.04 85.79 89.19 91.81 91.86 67.50 63.56 68.50 73.04 71.02 69.74 67.61 67.56 68.10 67.52
Common stock held in treasury, at cost -37.96 -37.96 -39.36 -39.15 -39.19 -42.02 -42.41 -41.80 -44.03 -45.16 -45.55 -23.07 -22.55 -22.25 -23.50 -22.02 -21.89 -21.48 -21.49 -21.87 -22.29
Total Johnson & Johnson shareholders’ equity 40.41% 40.93% 41.12% 40.58% 40.33% 39.69% 39.35% 39.50% 40.72% 41.04% 42.89% 39.20% 36.16% 40.99% 42.60% 42.96% 41.89% 40.67% 39.21% 39.44% 38.15%
Equity attributable to non-controlling interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total equity 40.41% 40.93% 41.12% 40.58% 40.33% 39.69% 39.35% 39.50% 40.72% 41.04% 42.89% 39.86% 36.16% 40.99% 42.60% 42.96% 41.89% 40.67% 39.21% 39.44% 38.15%
Total liabilities and shareholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2026-03-29), 10-K (reporting date: 2025-12-28), 10-Q (reporting date: 2025-09-28), 10-Q (reporting date: 2025-06-29), 10-Q (reporting date: 2025-03-30), 10-K (reporting date: 2024-12-29), 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04).

The overall capital structure remains relatively stable, with total liabilities typically fluctuating between 57% and 64% of the total balance sheet, while total equity generally ranges from 36% to 43%. A consistent balancing act is observed between the financing of assets through debt and shareholder equity over the analyzed period.

Current Liability Trends
Current liabilities exhibited a gradual increase from 23.72% in early 2021 to a peak of 30.81% in April 2023, subsequently stabilizing around 28%. A primary driver of this trend is the steady rise in accrued rebates, returns, and promotions, which grew from 6.91% to a high of 11.08% by September 2025. Conversely, accrued liabilities showed a general downward trajectory, declining from 7.66% to 3.68% by March 2026.
Long-Term Debt and Non-Current Obligations
Long-term debt, excluding the current portion, has remained volatile but generally ranges between 14% and 20%. A notable increase is observed starting in late 2023, with the ratio peaking at 20.44% in September 2025. Additionally, long-term taxes payable experienced a sharp contraction, falling from levels above 3% prior to 2024 to approximately 0.20% from June 2024 through March 2026.
Shareholders' Equity and Capital Adjustments
The equity structure underwent a significant transformation starting in October 2023. Common stock held in treasury increased dramatically from approximately -23% to a peak of -45.55%, indicating an aggressive increase in share repurchases. This was mirrored by a substantial rise in retained earnings and additional paid-in capital, which jumped from 67.56% in October 2021 to peaks exceeding 91% in late 2023. Despite these internal shifts in equity components, the total equity ratio remained resilient, fluctuating narrowly around the 40% mark for much of the period.
Liquidity and Short-Term Financing
Loans and notes payable demonstrate periodic spikes, most notably reaching 9.17% in April 2023 and 8.69% in March 2026, suggesting cyclical usage of short-term borrowing to manage liquidity. Accounts payable have remained remarkably consistent, generally hovering between 4.75% and 6.25% of total liabilities and equity.

AI Ask an analyst for more